Sarepta Therapeutics
Mansi Parasramka is currently the Associate Director of Gene Therapy at Sarepta Therapeutics, overseeing CMC analytical strategies and managing a team focused on various aspects of gene therapy product lifecycle. Prior experience includes roles at PPD as a Senior Research Scientist, where Mansi led a team executing cell and molecular analytical methods for RNA and Gene Therapy, and as a Research Scientist, responsible for qPCR method transfers for gene therapy clients. Previous positions at Mayo Clinic involved studying cholangiocarcinoma and optimizing drug screening methods for cancer treatment. Mansi's academic background includes a Ph.D. in Nutrition from Wayne State University and an M.S. in Biochemistry from Maharaja Sayajirao University, supported by significant publications in the field. Further education includes professional development in regulatory affairs and additional training in scientific methodologies.
This person is not in any teams
This person is not in any offices
Sarepta Therapeutics
11 followers
Sarepta Therapeutics, headquartered in Cambridge, Massachusetts, is a global biotechnology company on an urgent mission: engineer precision genetic medicine for rare diseases that devastate lives and cut futures short.